Table 1.
Characteristics of the studied subjects
| Characteristic | Valuea |
|
|---|---|---|
| Psoriasis patients (n = 44) | Healthy controls (n = 30) | |
| No. (%) of females | 17 (38.6) | 11 (36.7) |
| No. (%) of males | 27 (61.4) | 19 (63.3) |
| Mean age (range) (yr) | 31 (8–67) | 28 (15–58) |
| No. (%) of individuals with psoriasis type | ||
| Plaque type | 26 (59.1) | 0 |
| Guttate type | 18 (40.9) | 0 |
| No. (%) of individuals with psoriasis stage | ||
| Stationary | 24 (54.5) | 0 |
| Progressive | 20 (45.5) | 0 |
| Mean %BSA (range) | 6.34 (0.5–38) | |
| Mean PASI (range) | 4.84 (0.2–18) | |
| Mean total lesion area (range) (cm2) | 8.5 (1–34) | |
| Cell count (109/liter) | ||
| White blood cells | 7.17 ± 2.17 | |
| Red blood cells | 4.59 ± 0.58 | |
| Platelets | 231 ± 54.8 | |
| Cell % | ||
| Neutrophils | 60.95 ± 7.82 | |
| Lymphocytes | 30.05 ± 6.49 | |
| Monocytes | 6.13 ± 2.58 | |
| Eosinophils | 1.99 ± 2.21 | |
| Basophils | 0.061 ± 0.075 | |
| ESR (mm/h) | 6.27 ± 6.07 | |
| No. (%) of individuals | ||
| RF negative | 44 (100.0) | |
| RF positive | 0 (0) | |
| ASO negative | 27 (61.4) | |
| ASO positive | 17 (38.6) | |
a
Unless stated otherwise, values are means ± standard deviations.